ChemicalBook >> CAS DataBase List >>PACLITAXEL C
PACLITAXEL C
- CAS No.
- 153415-45-3
- Chemical Name:
- PACLITAXEL C
- Synonyms
- TAXOL C;PACLITAXEL C;Taxuyunnanine;Taxuyunnanine A;(-)-Taxuyunnanine;Paclitaxel EP IMpurity C;N-Debenzoyl-N-hexanoylpaclitaxel;Paclitaxel Impurity 3（Paclitaxel EP Impurity C）;Paclitaxel EP Impurity C N-debenzoyl-N-hexanoylpaclitaxel (paclitaxel C),;4,10β-bis(acetyloxy)-13α-[[(2R,3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-ylbenzoate(N-debenzoyl-N-hexanoylpaclitaxel
- CBNumber:
- CB91486202
- Molecular Formula:
- C46H57NO14
- Molecular Weight:
- 847.94
- MDL Number:
- MFCD00934688
- MOL File:
- 153415-45-3.mol
- MSDS File:
- SDS
Last updated:2023-06-08 09:03:04
| Boiling point | 932.3±65.0 °C(Predicted) |
|---|---|
| Density | 1.34±0.1 g/cm3 (20 ºC 760 Torr) |
| storage temp. | -20°C |
| solubility | Methanol: soluble |
| pka | 11.93±0.20(Predicted) |
| FDA UNII | L5P3TE6LS8 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS08,GHS06 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H340-H351-H372-H301-H360 | |||||||||
| Precautionary statements | P264-P270-P301+P310-P321-P330-P405-P501-P201-P202-P281-P308+P313-P405-P501-P260-P264-P270-P314-P501 | |||||||||
| NFPA 704 |
|
PACLITAXEL C price More Price(3)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | Y0000699 | Paclitaxel impurity C European Pharmacopoeia (EP) Reference Standard | 153415-45-3 | y0000699 | $150 | 2024-03-01 | Buy |
| TRC | P132510 | PaclitaxelC | 153415-45-3 | 2.5mg | $160 | 2021-12-16 | Buy |
| Crysdot | CD37000063 | TaxuyunnanineA 95+% | 153415-45-3 | 5mg | $450 | 2021-12-16 | Buy |
Synthesis of PACLITAXEL C from Benzenepropanoic acid, α-hydroxy-β-[[(2,2,2-trichloroethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
PACLITAXEL C Preparation Products And Raw materials
Raw materials
3'-N-debenzoyltaxol
Benzenepropanoic acid, α-hydroxy-β-[[(2,2,2-trichloroethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
Hexanoic acid
Preparation Products
Global( 78)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Zheyan Biotech Co., Ltd. | 18017610038 | zheyansh@163.com | CHINA | 3620 | 58 |
| Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28180 | 58 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14336 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
| China National Standard Pharmaceutical Corporation Limited | +8615391658522 | overseasales@yongstandards.com | China | 11927 | 58 |
| LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43348 | 58 |
| Guangzhou PI PI Biotech Inc | +86-020-81716320 +86-13602409664 | Sales@pipitech.com | China | 3635 | 55 |
| Guangzhou Younan Technology Co., Ltd | 020-020-82000279 18988968278 | sales@ubiochem.com | China | 2357 | 58 |
| J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 | jkinfo@jkchemical.com | China | 96815 | 76 |
| Chembest Research Laboratories Limited | 021-20908456 | sales@BioChemBest.com | China | 6011 | 61 |
153415-45-3(PACLITAXEL C)Related Search:
10-Deacetyl Paclitaxel Ethyl Analogue
Baccatine III
NDCWHEDPSFRTDA-NZSUPHSRSA-N
2-Debenzoyl Paclitaxel 2-Pentanoate
Paclitaxel
(4S,5R)-3-Benzoyl-2-(4-methoxyphenyl)-4-phenyl-5-oxazolidinecarboxylic acid
PACLITAXEL-D5
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
taxinine M
Paclitaxel Impurity 15 (Taxadiene-5-alpha-acetoxy-10-beta-ol)
1of4
(-)-Taxuyunnanine
N-Debenzoyl-N-hexanoylpaclitaxel
Taxuyunnanine
Taxuyunnanine A
Paclitaxel EP IMpurity C
TAXOL C
PACLITAXEL C
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-hexanamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-hexanamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl d
Paclitaxel EP Impurity C
N-debenzoyl-N-hexanoylpaclitaxel (paclitaxel C),
Paclitaxel Impurity 3（Paclitaxel EP Impurity C）
Paclitaxel impurity 9/Paclitaxel EP Impurity C/N-Debenzoyl-N-hexanoylpaclitaxel/(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-hexanamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,1
Benzenepropanoic acid, α-hydroxy-β-[(1-oxohexyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
4,10β-bis(acetyloxy)-13α-[[(2R,3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-ylbenzoate(N-debenzoyl-N-hexanoylpaclitaxel
153415-45-3
Aromatics
Chiral Reagents
Drug Analogues
Heterocycles
Intermediates & Fine Chemicals
Pharmaceuticals